Valuation: Nephros, Inc.

Market Cap 34.43M 30.83M 28.36M 25.7M 48.03M 3.27B 48.93M 338M 136M 1.72B 129M 126M 5.42B P/E 2026 *
20.2x
P/E 2027 * 12.2x
Enterprise Value 34.43M 30.83M 28.36M 25.7M 48.03M 3.27B 48.93M 338M 136M 1.72B 129M 126M 5.42B EV / Sales 2026 *
1.56x
EV / Sales 2027 * 1.34x
Free-Float
80.55%
Yield 2026 *
-
Yield 2027 * -
1 day-3.06%
1 week-10.20%
Current month-14.56%
1 month-14.56%
3 months-9.43%
6 months+0.32%
Current year-35.04%
1 week 3.08
Extreme 3.085
3.73
1 month 3.01
Extreme 3.01
3.89
Current year 2.66
Extreme 2.6629
5.46
1 year 2.66
Extreme 2.6629
6.42
3 years 1.36
Extreme 1.3643
6.42
5 years 0.91
Extreme 0.9051
8.15
10 years 0
Extreme 0
11.67
Manager TitleAgeSince
Chief Executive Officer 51 05/05/2023
Director of Finance/CFO 61 01/11/2023
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 69 19/09/2007
Director/Board Member 55 10/08/2018
Director/Board Member 58 08/09/2022
Date Insider Type Main position Quantity % Market Cap. Importance
14/9/26
Wexford Capital LP
OthersCompany -3,377,821 31.1030%
14/9/26 Others

Director

43,295 0.3987%
12/8/26 Free

Director

2,418 0.0223%
Change 5-day change 1-year change 3-year change Capi.($)
-3.06%-10.20%-43.49%+96.89% 34.43M
+1.10%-2.48%+16.39%+43.44% 92.83B
+3.28%+1.49%+16.25%+65.73% 74.34B
+1.16%-1.35%+7.66%+41.74% 46.05B
+6.77%+6.49%+10.68%+62.52% 27.01B
+0.25%-1.02%+3.05%+58.26% 19.72B
-2.33%-5.22%+40.32%+98.27% 15.93B
-2.73%-2.16%-0.87%+44.43% 9.62B
+1.47%+4.52%+20.11%+31.07% 9.9B
+3.34%-4.38%+12.66%+24.81% 5.94B
Average +0.93%-1.43%+8.28%+56.72% 30.14B
Weighted average by Cap. +1.85%-0.37%+14.39%+53.52%

Financials

2026 *2027 *
Net sales 22.14M 19.82M 18.24M 16.52M 30.88M 2.1B 31.46M 217M 87.3M 1.11B 83.07M 81.31M 3.49B 25.66M 22.98M 21.14M 19.15M 35.8M 2.44B 36.47M 252M 101M 1.28B 96.28M 94.24M 4.04B
Net income 1.76M 1.58M 1.45M 1.32M 2.46M 168M 2.51M 17.33M 6.96M 88.12M 6.62M 6.48M 278M 2.92M 2.61M 2.4M 2.18M 4.07M 277M 4.14M 28.65M 11.5M 146M 10.94M 10.71M 459M
Net Debt - -
Projected Income Statement - Annual - Nephros, Inc.
Logo Nephros, Inc.
Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
Employees
36
Date Price Change Volume
30/10/26 USD 3.170 -3.06% 12,416
29/10/26 USD 3.270 +3.15% 72,437
28/10/26 USD 3.170 -9.69% 236,015
27/10/26 USD 3.510 -3.31% 46,867
26/10/26 USD 3.630 +2.83% 39,086
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Nephros, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
3.170USD
Average target price
6.250USD
Spread / Average Target
+97.16%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Nephros, Inc.
  1. Stock Market
  2. Stocks
  3. NEPH Stock